Physician profile
Abid Qureshi
NPI 1386694602
$1,158,681.17
in general payments reported to CMS, 2019-2025
14 companies · $206K in 2025
The $206K reported for 2025 was more than what 96% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129K · 2020: $131K · 2021: $157K · 2022: $178K · 2023: $196K · 2024: $162K · 2025: $206K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $564K · Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $563,673.29 |
| Food and Beverage | $227.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $837,905.76 | 2019-2025 | Quartex |
| Orthofix Medical, INC. | $172,982.53 | 2023-2025 | Shoreline Asc, Physio-Stim, Shoreline Rt |
| Seaspine Orthopedics Corporation | $147,373.91 | 2019-2022 | |
| Expanding Innovations, INC. | $85.00 | 2024 | X-Pac |
| Providence Medical Technology, INC. | $76.04 | 2024 | |
| Alphatec Spine, INC | $57.37 | 2021-2022 | |
| Sanara Medtech INC. | $35.92 | 2021 | |
| Medtronic, INC. | $29.10 | 2021-2023 | Synchromedii |
| Nevro Corp. | $28.34 | 2023 | Senza |
| Amgen INC. | $26.07 | 2022 | |
| Fidia Pharma USA INC. | $22.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.61 | 2023 | |
| Team_makena_llc | $20.00 | 2019 | |
| Ethicon US, LLC | $15.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abid Qureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.